Last edition
News about "Small Molecule Drugs"
Biogen Closes Acquisition of RayThera
Biogen completes the acquisition of RayThera Inc., adding a phase 1 lead program to strengthen its pipeline and advance innovative therapeutic development.
Small Molecule Drugs | 07/08/2026 | By News Bureau
Biogen to Acquire RayThera in Deal Worth Up to USD 1 Billion to Strengthen Immunology Pipeline
Biogen has agreed to acquire immunology-focused biotech firm RayThera in a deal worth up to USD 1 billion, gaining a portfolio of anti-inflammatory drug candidates and strengthening its pipeline for immune-mediated diseases.
Small Molecule Drugs | 20/06/2026 | By News Bureau | 138
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy